$CVM continues to be in the spotlight, with stock hitting 52 week highs.  Bulls think that the rewards may be enormous if the company can finish its clinical trial, while bears think the trial has already failed.

Stocks covered on the show:

$CVM: Cel-Sci

$BPTH: BioPath Holdings

$AGN: Allergan

$ABBV AbbeVie

$PYX Pyxus

$BPMX : BiopharmX

Check out the Behind The Bid website (new!).  Morning post and other stock related news.  

https://www.behindthebid.com/posts/morning-stock-news-roundup-for-tuesday-june-25th